Ownership and insider activity for Cencora, Inc. (COR): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment.
Price
| Price | $330.84 (closing price, October 30, 2026) |
| Market Cap | $63.1B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-01 | SANCHEZ ROBERT E | A-Award | 275 | |
| 2026-10-01 | Krikorian Lazarus | S-Sale | 986 | $299K |
| 2026-10-01 | SANCHEZ ROBERT E | |||
| 2026-09-16 | GREENBERG LON R | S-Sale | 1,280 | $411K |
| 2026-09-01 | Krikorian Lazarus | S-Sale | 985 | $321K |
| 2026-08-24 | Campbell Elizabeth S | S-Sale | 11,300 | $3.7M |
| 2026-07-31 | NALLY DENNIS M | A-Award | 113 | $35K |
| 2026-07-31 | Cooper Ellen | A-Award | 97 | $30K |
| 2026-07-31 | Tyler Lauren M | A-Award | 97 | $30K |
| 2026-06-30 | Battaglia Silvana | A-Award | 58 | $14K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.74B | $2.44B | $2.49B | $3.37B | $4.60B | $2.55B | $3.53B | $2.69B | $3.23B | $4.39B |
| Short-term Investments | $26.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $9.18B | $10.30B | $11.31B | $12.39B | $14.30B | $18.39B | $18.63B | $20.91B | $23.87B | $25.23B |
| Inventory | $10.72B | $11.46B | $11.92B | $11.06B | $12.59B | $15.37B | $17.09B | $17.45B | $19.00B | $20.49B |
| Total Current Assets | $22.79B | $24.30B | $25.89B | $28.13B | $33.02B | $38.80B | $39.59B | $42.80B | $47.72B | $52.24B |
| Property, Plant & Equipment | $1.53B | $1.80B | $1.89B | $1.77B | $1.93B | $3.23B | $3.08B | $3.15B | $3.32B | $4.09B |
| Goodwill | $5.99B | $6.04B | $6.66B | $6.71B | $6.71B | $9.03B | $8.50B | $9.57B | $9.32B | $13.68B |
| Intangible Assets | $2.97B | $2.83B | $2.95B | $2.29B | $1.89B | $5.26B | $4.33B | $4.43B | $4.00B | $3.77B |
| Total Assets | $33.59B | $35.32B | $37.67B | $39.17B | $44.27B | $57.34B | $56.56B | $62.56B | $67.10B | $76.59B |
| Accounts Payable | $23.93B | $25.40B | $26.84B | $28.39B | $31.71B | $38.01B | $40.19B | $45.84B | $50.94B | $54.72B |
| Short-term Debt | $610.2M | $12.1M | $151.7M | $139.0M | $593.8M | $475.6M | $1.23B | $823.8M | $781.1M | $371.6M |
| Total Current Liabilities | $25.24B | $26.77B | $27.87B | $29.58B | $33.85B | $41.36B | $43.48B | $48.83B | $54.28B | $57.82B |
| Long-term Debt | $3.58B | $3.43B | $4.16B | $4.03B | $4.00B | $7.33B | $5.50B | $5.07B | $4.84B | $8.96B |
| Total Liabilities | $31.51B | $33.25B | $34.97B | $36.47B | $45.11B | $56.75B | $56.49B | $61.89B | $66.31B | $74.84B |
| Retained Earnings | $2.30B | $2.40B | $3.72B | $4.24B | $518.3M | $1.67B | $2.98B | $4.32B | $5.42B | $6.53B |
| Total Equity | $2.13B | $2.06B | $2.93B | $2.88B | -$1.02B | $223.4M | -$211.6M | $522.0M | $645.9M | $1.51B |
| Total Debt | $4.46B | $3.79B | $4.66B | $4.49B | $4.98B | $8.75B | $7.59B | $6.82B | $6.65B | $10.75B |
| Net Debt | $1.69B | $1.36B | $2.17B | $1.12B | $385.4M | $6.20B | $4.06B | $4.13B | $3.42B | $6.35B |
| Working Capital | -$2.45B | -$2.46B | -$1.98B | -$1.45B | -$833.2M | -$2.56B | -$3.89B | -$6.03B | -$6.56B | -$5.58B |
Financial Health
| Debt / Equity | 3.84 |
| Current Ratio | 0.93 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 4.87 |
Profitability
| Return on Equity | 106.43% |
| Return on Invested Capital | 12.75% |
| Return on Assets | 3.13% |
| Gross Margin | 3.71% |
| Operating Margin | 1.30% |
| Net Margin | 0.79% |
Related companies: HSIC · MCK · CAH · 0JZU.L · 0HF3.L · 0HTG.L · 0L3C.L · 0ROG.L
Explore sector: Healthcare · Medical - Distribution
More sections of COR: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks